Articles > Popular publications > PR Newswire press releases > January-March 2004 > Monday, March 8

Article: FORADIL(R) CERTIHALER(TM) Receives First European Approval.

Article from:
PR Newswire
Article date:
March 8, 2004
Copyright

SkyePharma PLC ( LSE: SKP) announces today that the Swiss pharmaceutical regulatory authority has approved FORADIL(R) CERTIHALER(TM) (formoterol fumarate inhalation powder). FORADIL(R) CERTIHALER(TM) was co-developed by SkyePharma PLC and Novartis Pharma AG. CERTIHALER(TM) is a trademark of Novartis. FORADIL(R) CERTIHALER(TM) was submitted for regulatory review in Europe on a country-by- country basis beginning in December 2002. FORADIL(R) CERTIHALER(TM) was also submitted for regulatory review in the US in December 2002 and the US Food and Drug Administration issued an "Approvable" letter for the product in October 2003. FORADIL(R) CERTIHALER(TM) embodies two ... 







Read all of this article with a FREE trial
















Related newspaper, magazine, and journal articles:









  




 

    

 
 
   
 


   
  
  Article: SkyePharma Announces FORADIL(R) CERTIHALER(TM) ...

  
  PR Newswire; 
  September 7, 2005 ;  
  
  
 
  700+ words
... ... Novartis Pharma AG (Novartis) has launched FORADIL(R) CERTIHALER(TM) (formoterol fumarate inhalation powder ... pharmaceutical regulatory authority approved FORADIL(R) CERTIHALER(TM) in June. FORADIL(R) CERTIHALER(TM) is a trademark ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: FORADIL(R) CERTIHALER(TM) Receives 'Approvable' ...

  
  PR Newswire; 
  October 22, 2003 ;  
  
  
 
  700+ words
... ... approvable" letter for FORADIL(R) CERTIHALER(TM) (formoterol fumarate ... the US in December 2002. FORADIL(R) CERTIHALER(TM) embodies two proprietary ... the active ingredient in FORADIL(R) CERTIHALER(TM), is a long-acting ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: Novartis Submits NDA for SkyePharma Co-Developed ...

  
  PR Newswire; 
  December 20, 2002 ;  
  
  
 
  700+ words
... ... health authorities in EU for FORADIL(R) CERTIHALER(TM) (formoterol fumarate inhalation ... and marketing rights to all FORADIL products. Schering-Plough currently markets FORADIL(R) AEROLIZER(TM) (formoterol fumarate inhalation ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: SkyePharma Announces FORADIL CERTIHALER Approved in ...

  
  PR Newswire; 
  June 20, 2005 ;  
  
  
 
  700+ words
... ... authority has approved FORADIL(R) CERTIHALER(TM) (formoterol fumarate ... disease ("COPD"). FORADIL(R) CERTIHALER(TM) was co-developed by ... and Novartis Pharma AG. FORADIL(R) CERTIHALER(TM) is a trademark of Novartis ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: NOVARTIS' FORADIL GAINS US APPROVAL FOR THE MAINTENANCE ...

  
  PR Newswire; 
  February 19, 2001 ;  
  
  
 
  700+ words
... ... growth potential now a reality for Foradil Aerolizer(TM) inhaler PR Newswire, London ... long-lasting bronchodilator Foradil(r) (formoterol fumarate inhalation ... The US marketing approval of Foradil is an important milestone for Novartis ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: Foradil Certihaler receives approvable letter from FDA.

  
  Biotech Week; 
  November 19, 2003 ;  
  
  
 
  700+ words
... ... issued an "approvable" letter for Foradil Certihaler (formoterol fumarate inhalation ... of certain outstanding issues. The Foradil Certihaler was codeveloped by SkyePharma PLC and Novartis Pharma AG. The Foradil Certihaler was submitted for regulatory ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: Schering-Plough and Novartis Sign Agreement Giving ...

  
  PR Newswire; 
  November 1, 2002 ;  
  
  
 
  700+ words
... ... distribution and marketing rights to Novartis' FORADIL(R) AEROLIZER(R) (formoterol fumarate ... will pay a royalty on its net sales of FORADIL AEROLIZER. Specific financial terms of ... president of Schering Laboratories. "FORADIL AEROLIZER promises to be an important ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: Study shows Foradil Aerolizer more effective than ...

  
  Immunotherapy Weekly; 
  May 8, 2002 ;  
  
  
 
  700+ words
... ... net) -- Long-term treatment with Foradil Aerolizer (formoterol fumarate inhalation ... study confirms the long-term efficacy of Foradil Aerolizer used twice daily in controlling ... symptoms and shows that treatment with Foradil Aerolizer is superior to theophylline ... 







   
 

























 



 





 






Newsweek
Harper's Magazine
The Washington Post
Chicago Tribune
Crain's Chicago Business
PRNewswire
Pediatric News
The Nation
Advertising Age
The Economist (US)
A FREE trial gives you access to over 80 million articles!
Access over 6,500 publications with a FREE trial!


  



Find articles, research, and archives